Q&A With Robert Lisak from Wayne State University School of Medicine: New Research and Treatments Highlight CMSC Agenda

Video

It was a busy few days in Indianapolis for the Consortium of Multiple Sclerosis Centers. The annual meeting highlighted not only new treatments currently available to patients but also work coming down the pipeline for future options.

It was a busy few days in Indianapolis for the Consortium of Multiple Sclerosis Centers. The annual meeting highlighted not only new treatments currently available to patients but also work coming down the pipeline for future options.

Robert P. Lisak, MD, from the Wayne State University School of Medicine said advancements in the treatment of the relapsing form of the condition, and new research about the progressive form made for an informative session. Lisak, who also serves as President of the Consortium of Multiple Sclerosis Centers said he was also encouraged to see many new attendees at the event and the contributions made by first time people at the annual conference.

Related Videos
HCPLive Five at ACC 2024 | Image Credit: HCPLive
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Veraprapas Kittipibul, MD | Credit: X.com
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.